Quantcast

Latest PAREXEL International Corporation Stories

2015-05-04 12:26:53

BOSTON, May 4, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the UBS Healthcare Conference on Monday, May 18, 2015, in New

2015-04-29 16:30:00

- Gross new business wins of $942.4 million, up 20.6% year-over-year; net book-to-bill ratio of 1.30; backlog at $5.19 billion BOSTON, April 29, 2015 /PRNewswire/ -- PAREXEL

2015-04-24 08:31:40

Award highlights Company's innovative Perceptive MyTrials® Data-Driven Monitoring solution and development team BOSTON, April 24, 2015 /PRNewswire/ -- PAREXEL International

2015-04-08 08:29:30

- Bachelor of Science Degree in Clinical Research offered in Europe BOSTON, April 8, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical

2015-03-31 08:35:47

BOSTON, March 31, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today introduced the latest version of its

2015-03-26 08:35:08

~ Will add global scale to meet growing demand for safety services BOSTON, March 26, 2015 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL), a global

2015-03-17 08:32:40

BOSTON, March 17, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has been named

2015-02-18 08:30:51

Global network accelerates patient recruitment and clinical trial start-up times BOSTON, Feb.

2015-02-10 08:33:36

Company acknowledged for excellence in employer-sponsored training and development programs BOSTON, Feb.